Page last updated: 2024-12-05

aminoethyl-aminopropyl-trimethoxysilane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Aminoethyl-aminopropyl-trimethoxysilane (AAPTMS) is a silane coupling agent commonly used to improve adhesion between organic and inorganic materials. It is a bifunctional molecule with an amine group at one end and a trimethoxysilyl group at the other. The amine group reacts with organic polymers, while the trimethoxysilyl group hydrolyzes in the presence of moisture to form silanol groups that react with the surface of inorganic materials. This creates a strong chemical bond between the two materials, improving their adhesion and compatibility. AAPTMS is used in a variety of applications, including coatings, composites, and adhesives. It is also used to modify the surface properties of materials, such as improving hydrophobicity or increasing adhesion to glass or metal.'

aminoethyl-aminopropyl-trimethoxysilane: RN given refers to parent cpd; a silylating agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15659
CHEMBL ID3188366
SCHEMBL ID19549
MeSH IDM0048456

Synonyms (109)

Synonym
AKOS008901325
1760-24-3
1,2-ethanediamine, n-[3-(trimethoxysilyl)propyl]-
n-[3-(trimethoxysilyl)propyl]ethane-1,2-diamine
gf 91
silicone a-1120
a 0700
1,2-ethanediamine, n-(3-(trimethoxysilyl)propyl)-
ethylenediamine, n-(3-(trimethoxysilyl)propyl)-
einecs 217-164-6
aas-m
nuca 1120
kbm 603
en-aptas
n-(3-(trimethoxysilyl)propyl)-1,2-ethanediamine
silane, (3-(2-aminoethyl)aminopropyl)trimethoxy-
ap 132
n-(3-(trimethoxysilyl)propyl)ethylenediamine
prosil 3128
dow corning z-6020 silane
brn 0636230
z 6020
n-(3-trimethoxysilylpropyl)-ethylenediamine
sh 6020
3-(2-aminoethylamino)propyltrimethoxysilane
n-(2-aminoethyl-3-aminopropyl)trimethoxysilane
[3-(2-aminoethylamino)propyl]trimethoxysilane, technical grade, >=80%
n-[3-(trimethoxysilyl)propyl]ethylenediamine, 97%
NCGC00164238-01
aminoethyl-aminopropyl-trimethoxysilane
n-(3-trimethoxysilylpropyl)ethylenediamine
n-(2-aminoethyl)-3-aminopropyltrimethoxysilane
A0774
n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine
[3-(2-aminoethyl)aminopropyl]trimethoxysilane
5-trimethoxysilylpentane-1,3-diamine;[3-(2-aminoethyl)aminopropyl]trimethoxysilane
A812143
NCGC00164238-02
1,2-ethanediamine, n1-(3-(trimethoxysilyl)propyl)-
28zcs5ga8g ,
unii-28zcs5ga8g
ec 217-164-6
dtxsid5027433 ,
NCGC00256996-01
cas-1760-24-3
dtxcid607433
tox21_303228
tox21_201649
NCGC00259198-01
c8h22n2o3si
FT-0629099
n-(2-aminoethyl)-3-(trimethoxysilyl)propylamine
[3-(2-aminoethylamino)propyl]trimethoxysilane
n-[3-(trimethoxysilyl)propyl]ethylenediamine
n1-(3-(trimethoxysilyl)propyl)ethane-1,2-diamine
S00625
3-(2-aminoethyl)-3-aminopropyltrimethoxysilane
Z-6020 ,
n-2-aminoethyl-3-aminopropyltrimethoxysilane
[3-(2-aminoethyl)aminopropyl]-trimethoxysilane
h2nc2h4nhc3h6si(och3)3
nh2ch2ch2nhch2ch2ch2si(och3)3
n-2-amino-ethyl-3-aminopropyltrimethoxysilane
nh2ch2ch2nh(ch2)3si(och3)3
(ch3o)3si(ch2)3nh(ch2)2nh2
n-(beta-aminoethyl)-gamma-aminopropyltrimethoxysilane
3-[n-(2-aminoethyl)]aminopropyltrimethoxysilane
SCHEMBL19549
6-amino-4-azahexyltrimethoxysilane
damo-p
damo-t
aminoethylaminopropyltrimethoxysilane
(2-aminoethyl)(3-(trimethoxysilyl)propyl)amine
dynasylan damo
(.beta.-aminoethyl)-.gamma.-aminopropyltrimethoxysilane
(trimethoxysilylpropyl)ethylenediamine
(gamma.-ethylenediaminepropyl)trimethoxysilane
n-(3-(trimethoxysilyl)propyl)ethane-1,2-diamine
1,2-ethanediamine, n1-[3-(trimethoxysilyl)propyl]-
dynasylan damo-p
n-[3-(trimethoxysilyl)propyl]-1,2-ethanediamine
aminoethylaminopropyltrimethoxy silane
petrarch a0700
dynasylan damo-t
silane, trimethoxy-[3[n-(2-aminoethyl)]aminopropyl]-
union carbide a-1120
dow corning z-6020
n-(.beta.-aminoethyl)-.gamma.-aminopropyltrimethoxysilane
n-(2-aminoethyl)-.gamma.-aminopropyltrimethoxysilane
n-.beta.-(aminoethyl)-.gamma.-aminopropyl trimethoxy silane
CHEMBL3188366
3-(2-aminoethyl) 3-aminopropyltrimethoxysilane
mfcd00008173
n-aminoethyl-g-aminopropyltrimethoxysilane
J-011155
AS-13515
CS-0090508
D74925
Q27254353
3-(2-aminoethylamino)propyl]trimethoxysilane
29226-47-9
(2-aminoethyl)[3-(trimethoxysilyl)propyl]amine
[3- (2-aminoethyl)-aminopropyl]trimethoxysilane
n-(beta-aminoethyl)gamma-aminopropytrimethoxysilane
n-(2-aminoethyl)-3-aminopropyltrimethoxysilane diamino
3-(2-aminoethylane )-3aminopropyltrimethoxysilane
n-[3-(trimethoxysilyl)propyl]ethylenediamine, 95%
n-(2-aminoethyl-3-aminopropyl) trimethoxysilane
3-(2-aminoethylamino)propyltrimethoxysilane, 96% 2

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" In this study, the exact modulation of MH on CB2 receptor activity was elucidated and its endocannabinoid substrate-specific inhibition (SSI) of cyclooxygenase-2 (COX-2) and CNS bioavailability are described for the first time."( 4'-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation.
Charles, RP; Chicca, A; Gachet, MS; Gertsch, J; Petrucci, V; Schuehly, W, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
SMAD family member 2Homo sapiens (human)Potency29.14660.173734.304761.8120AID1346859; AID1346924
SMAD family member 3Homo sapiens (human)Potency29.14660.173734.304761.8120AID1346859; AID1346924
GLI family zinc finger 3Homo sapiens (human)Potency8.75800.000714.592883.7951AID1259369
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency69.56730.013326.981070.7614AID1346978
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency39.12060.003041.611522,387.1992AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency13.88050.005428.02631,258.9301AID1346982
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.03890.001024.504861.6448AID743215
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency5.49410.023723.228263.5986AID743222
caspase-3Homo sapiens (human)Potency69.56730.013326.981070.7614AID1346978
aryl hydrocarbon receptorHomo sapiens (human)Potency43.89400.000723.06741,258.9301AID743085
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency0.69570.001723.839378.1014AID743083
Caspase-7Cricetulus griseus (Chinese hamster)Potency27.69520.006723.496068.5896AID1346980
caspase-3Cricetulus griseus (Chinese hamster)Potency27.69520.006723.496068.5896AID1346980
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.45)18.7374
1990's3 (10.34)18.2507
2000's14 (48.28)29.6817
2010's11 (37.93)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.38 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index42.88 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.33%)4.05%
Observational0 (0.00%)0.25%
Other29 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]